dimethyl itaconate has been researched along with Psoriasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akira, S; Amarasinghe, GK; Apte, RS; Artyomov, MN; Auclair, K; Bambouskova, M; Biller, SA; Bregman, H; de Guzman Strong, C; Duncan, D; Gorvel, L; Hai, T; Huang, LH; Johnson, B; Johnson, K; Jovanovic, M; Keskin, A; Kim, H; Klechevsky, E; Korenfeld, D; Lampropoulou, V; Loginicheva, E; Mathyer, ME; Randolph, GJ; Roddy, TP; Santeford, A; Satoh, T; Sehgal, R; Sergushichev, A; Soares, MP; Stewart, KM | 1 |
1 other study(ies) available for dimethyl itaconate and Psoriasis
Article | Year |
---|---|
Electrophilic properties of itaconate and derivatives regulate the IκBζ-ATF3 inflammatory axis.
Topics: Activating Transcription Factor 3; Animals; Cells, Cultured; Cytokines; Female; Gene Expression Regulation; Glutathione; Humans; I-kappa B Proteins; Inflammation; Interleukin-6; Keratinocytes; Macrophages; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Psoriasis; Stress, Physiological; Succinates; Toll-Like Receptors | 2018 |